Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
This study is completed. It focuses on depression and currently lists study information in Canada.
In Toronto
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on depression and currently lists study information in Canada.
In TorontoThis study is completed. It focuses on depression and currently lists study information in France.
In ParisThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In Glen OaksThis study is completed. It focuses on depression and currently lists study information in the United States.
In New YorkThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In West HavenThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In San DiegoThis study has public registry information. It focuses on bipolarity and currently lists study information in Global.
In GlobalThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In ClevelandThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
In IrvineThis study has public registry information. It focuses on bipolarity and currently lists study information in South Korea.
In SeoulThis study is completed. It focuses on addiction and currently lists study information in the United States.
In BelmontThis study is completed. It focuses on bipolarity and currently lists study information in the United States.
Multiple locations, including BirminghamHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.